Athena M. Countouriotis
2015
In 2015, Athena M. Countouriotis earned a total compensation of $2.7M as Senior Vice President and Chief Medical Officer at Halozyme Therapeutics.
Compensation breakdown
| Bonus | $300,000 |
|---|---|
| Non-Equity Incentive Plan | $202,000 |
| Option Awards | $1,465,325 |
| Salary | $426,967 |
| Stock Awards | $299,700 |
| Other | $7,621 |
| Total | $2,701,613 |
Countouriotis received $1.5M in option awards, accounting for 54% of the total pay in 2015.
Countouriotis also received $300K in bonus, $202K in non-equity incentive plan, $427K in salary, $299.7K in stock awards and $7.6K in other compensation.
Rankings
In 2015, Athena M. Countouriotis' compensation ranked 3,551st out of 13,638 executives tracked by ExecPay. In other words, Countouriotis earned more than 74.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,551 out of 13,638 | 74th |
Division Manufacturing | 1,296 out of 5,187 | 75th |
Major group Chemicals And Allied Products | 470 out of 1,857 | 75th |
Industry group Drugs | 376 out of 1,531 | 75th |
Industry Biological Products, Except Diagnostic Substances | 67 out of 260 | 74th |
Source: SEC filing on March 24, 2017.
Countouriotis' colleagues
We found four more compensation records of executives who worked with Athena M. Countouriotis at Halozyme Therapeutics in 2015.